Exabis Library
Welcome to the e-CCO Library!
P679: Development of a novel auto-injector of subcutaneous CT-P13 infliximab: Phase I randomised, open-label, single-dose trial to compare the pharmacokinetics and safety to pre-filled syringe in healthy subjects
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P679: Inflammatory Bowel Disease and cancer risk in the IBSEN study after 30 years of follow-up.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P679: Infliximab biosimilar CT-P13 in inflammatory bowel disease patients that require intensification treatment
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P679: Is the burden of obesity in IBD bigger than just weight?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P679: Risk factors for disease relapse after stepping down from combination to anti-TNF monotherapy in children with IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P679: The keystone bacterium Christensenella minuta improves colitis in in vivo preclinical Inflammatory Bowel Disease models
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P680 Biological treatment and potential risk of adverse postoperative outcome in patients with inflammatory bowel disease: An open-source expert panel review of the current literature and perspectives
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P680: A real-life experience of Crohn's Disease Exclusion Diet use at disease onset and as an add-on therapy in pediatric Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P680: Epidemiology of Inflammatory Bowel Disease in Poland 2009-2020: nationwide data
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P680: Long-term efficacy of ustekinumab with and without concomitant immunosuppressants for Crohn’s disease: results from IM-UNITI long-term extension through 2 years
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P680: Machine learning (ML) in RCU-operated patients: Can we predict postoperative complications?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P680: Quality of sex life in patients with inflammatory bowel disease: the gastroenterologists' perspective
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P680: Similar gut bacterial composition between patients with ulcerative colitis and healthy controls in a high prevalence population: a cross-sectional study of the Faroe Islands IBD cohort
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P681 Efficacy of vedolizumab for the prevention of postoperative recurrence in Crohn’s disease: Data from clinical practice from the ENEIDA registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P681: Assessing internet based information used to aid patient decision making in surgery for perianal Crohn's fistula
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P681: Effectiveness and safety of oral Tacrolimus salvage therapy for acute severe ulcerative colitis: a retrospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P681: Higher in vitro mucin degradation, but no increased paracellular permeability by faecal water from Crohn’s disease patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P681: Impact of Crohn’s disease on survival in Korean patients with small bowel adenocarcinoma
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P681: Systematic review and meta-analysis of the safety and efficacy of intra-fistular injections of mesenchymal stem cells in clinical trials and observational cohort studies
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P681: Ustekinumab therapy induced clinically meaningful improvement and remission as measured by the Inflammatory Bowel Disease Questionnaire: Results from the phase 3 UNIFI induction and maintenance studies
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM